Copyright
©The Author(s) 2017.
World J Cardiol. Feb 26, 2017; 9(2): 109-133
Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.109
Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.109
Ref. | Year | n | Modality | Main findings | Follow-up |
Ahn et al[13] | 2013 | 135 | Echo | Adverse LV remodelling (> 20% inc. LVEDV) at 6 mo was IP 3 yr MACE. MACE rate approximately 25% in patients with adverse LV remodelling vs approximately 6% in non-remodelled patients | 981 d |
Hombach et al[6] | 2005 | 110 | CMR | Baseline LVEDV was IP for MACE (P = 0.038) | 225 d |
St John Sutton et al[39] | 2003 | 512 | Echo | Percentage change in LV area (surrogate for LV volume) between baseline echo and follow-up at 12 mo was IP for ventricular ectopy and VT | 24 mo |
Bolognese et al[12] | 2002 | 284 | Echo | Baseline LVESV was IP for cardiac death and MACE. Components of MACE higher in patients with adverse remodelling (> 20% inc. LVEDV: Mortality 14% vs 5%, MACE 18% vs 10%) | 5 yr |
Otterstad et al[40] | 2001 | 712 | Echo | Increase in LVESV between acute scan at 7 d and echo at 3 mo strongest IP for MACE | 24 mo |
St John Sutton et al[41] | 1994 | 512 | Echo | LV end-diastolic area (RR 1.1) and LV end-systolic area (RR 1.1) on baseline echo, and %-change in LV area at 12 mo echo (RR 1.55) were strongest IPs for MACE | 12 mo |
White et al[30] | 1987 | 605 | LV gram | LVESV of LV gram at 4 wk was strongest IP of long-term mortality (P < 0.0001) | 78 mo |
- Citation: Khan JN, McCann GP. Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction. World J Cardiol 2017; 9(2): 109-133
- URL: https://www.wjgnet.com/1949-8462/full/v9/i2/109.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i2.109